Andorra vs Canada: Proportion of the target population who received the final dose of
Andorra
82.0%
in 2024
Canada
86.0%
in 2024
Andorra rank
20th
Canada rank
18th
Proportion of the target population who received the final dose of over time
- Andorra
- Canada
How they compare
Canada currently reports 86.0% against 82.0% in Andorra, a difference of 4.0%.
Across all 7 years both countries report, Canada has been ahead every year.
Andorra ranks 20th and Canada ranks 18th of 107 countries.
Canada has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Andorra | Canada | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 56.5% | 83.0% | 26.5% | Canada |
| 2020s | 82.0% | 86.4% | 4.4% | Canada |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received the final dose of, Andorra or Canada?
- Canada, at 86.0% against 82.0% in Andorra as of 2024.
- What is the difference in proportion of the target population who received the final dose of between Andorra and Canada?
- 4.0%, with Canada ahead.
- How many years of comparable data are there for Andorra and Canada?
- 7 years are reported by both, from 2018 to 2024.
- How do Andorra and Canada rank globally for proportion of the target population who received the final dose of?
- Andorra ranks 20th and Canada ranks 18th of 107 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received the final dose of human papillomavirus (HPV) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.